LEVOXINE (Sun Pharma ANZ Pty Ltd)
Product name
LEVOXINE
Sponsor
Date registered
Approval time
173 (255 working days)
Active ingredients
levothyroxine sodium
Registration type
New generic medicine
Indication
LEVOXINE (tablet) is indicated for the management of demonstrated thyroid hormone deficiency.
LEVOXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine